These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17479218)

  • 1. Analysis of recombinant protein toxicity in E. coli through a phage lambda-based genetic screening system.
    Fernández G; Vera A; Villaverde A; Martínez MA
    Biotechnol Lett; 2007 Sep; 29(9):1381-6. PubMed ID: 17479218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An E. coli expression system which detoxifies the HIV protease.
    Korant BD; Rizzo CJ
    Biomed Biochim Acta; 1991; 50(4-6):643-6. PubMed ID: 1801736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epistasis among deleterious mutations in the HIV-1 protease.
    Parera M; Perez-Alvarez N; Clotet B; Martínez MA
    J Mol Biol; 2009 Sep; 392(2):243-50. PubMed ID: 19607838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heterologous substrate assay for the HIV-1 protease engineered in Escherichia coli.
    Stebbins J; Deckman IC; Richardson SB; Debouck C
    Anal Biochem; 1996 Nov; 242(1):90-4. PubMed ID: 8923970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV protease cleaves poly(A)-binding protein.
    Alvarez E; Castelló A; Menéndez-Arias L; Carrasco L
    Biochem J; 2006 Jun; 396(2):219-26. PubMed ID: 16594896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of a microbial assay for screening anti-human immunodeficiency virus type-1 protease inhibitors].
    Leng Q; Tao P; Wang L; Gao Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Apr; 21(2):140-5. PubMed ID: 12569671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and expression of the HIV protein in Escherichia coli cell-free system.
    Chen H; Xu Z; Yin X; Cen P
    Appl Microbiol Biotechnol; 2007 Nov; 77(2):347-54. PubMed ID: 17899071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bacteriophage lambda-based genetic screen for characterization of the activity and phenotype of the human immunodeficiency virus type 1 protease.
    Martínez MA; Cabana M; Parera M; Gutierrez A; Esté JA; Clotet B
    Antimicrob Agents Chemother; 2000 May; 44(5):1132-9. PubMed ID: 10770741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A set of UV-inducible autolytic vectors for high throughput screening.
    Li S; Xu L; Hua H; Ren C; Lin Z
    J Biotechnol; 2007 Jan; 127(4):647-52. PubMed ID: 16950533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for HIV protease inhibitors by protection against activity-mediated cytotoxicity in Escherichia coli.
    Cheng YS; Lo KH; Hsu HH; Shao YM; Yang WB; Lin CH; Wong CH
    J Virol Methods; 2006 Oct; 137(1):82-7. PubMed ID: 16849028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic protease switch.
    Sikorski R; Peters R
    Science; 1998 Apr; 280(5362):456. PubMed ID: 9575087
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of lambda phage shuttle vectors in transgenic mice for development of a short term mutagenicity assay.
    Short JM; Kohler SW; Provost GS; Feick A; Kretz PL
    Prog Clin Biol Res; 1990; 340A():355-67. PubMed ID: 1697073
    [No Abstract]   [Full Text] [Related]  

  • 13. Exonuclease requirements for recombination of lambda-phage in recD mutants of Escherichia coli.
    Dermić D; Zahradka D; Petranović M
    Genetics; 2006 Aug; 173(4):2399-402. PubMed ID: 16702415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid screening method for biological activity of human immunodeficiency virus proteinase inhibitors by using a recombinant DNA-derived bacterial system.
    Sedlácek J; Fábry M; Horejsí M; Brynda J; Luftig RB; Majer P
    Anal Biochem; 1993 Dec; 215(2):306-9. PubMed ID: 8122796
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants.
    Kozísek M; Bray J; Rezácová P; Sasková K; Brynda J; Pokorná J; Mammano F; Rulísek L; Konvalinka J
    J Mol Biol; 2007 Dec; 374(4):1005-16. PubMed ID: 17977555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization.
    Kafaie J; Dolatshahi M; Ajamian L; Song R; Mouland AJ; Rouiller I; Laughrea M
    Virology; 2009 Mar; 385(1):233-44. PubMed ID: 19070880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directed evolution of a protein container.
    Wörsdörfer B; Woycechowsky KJ; Hilvert D
    Science; 2011 Feb; 331(6017):589-92. PubMed ID: 21292977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of carcinogens with the prophage lambda cIts857 induction test.
    Ho YL; Ho SK
    Cancer Res; 1981 Feb; 41(2):532-6. PubMed ID: 6449995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Escherichia coli dnaK-deletion mutant infected by lambdaDE3 for overexpression and purification of recombinant GrpE proteins.
    Sugimoto S; Higashi C; Yoshida H; Sonomoto K
    Protein Expr Purif; 2008 Jul; 60(1):31-6. PubMed ID: 18434193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering the E. coli beta-galactosidase for the screening of antiviral protease inhibitors.
    Vera A; Arís A; Daura X; Martínez MA; Villaverde A
    Biochem Biophys Res Commun; 2005 Apr; 329(2):453-6. PubMed ID: 15737608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.